Precision Medicine for Immunotherapy-Resistant Advanced Esophageal Cancer
Clinical trial NCT07653451 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07653451
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.